Paola Rondón-Villarreal

Dr. Paola Rondón-Villarreal

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in The R Journal
Verified
Journal Article
Open access
DODaniel Osorio
Daniel Osorio
PRPaola Rondón-Villarreal
Paola Rondón-Villarreal
RTRodrigo Torres
Rodrigo Torres

1 January 2014
Verified
Book Chapter
Closed access
PDF file
JDJennifer Andrea Ruiz Duran
Jennifer Andrea Ruiz Duran
JCJhon Calderon
Jhon Calderon
PRPaola Rondón-Villarreal
Paola Rondón-Villarreal
RTRodrigo Torres
Rodrigo Torres

28 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
JRJosé Ropero
José Ropero
JRJ.F. Redondo-Ortega
J.F. Redondo-Ortega
YGYuli Juliana Galvis-Curubo
Yuli Juliana Galvis-Curubo
PRPaola Rondón-Villarreal
Paola Rondón-Villarreal
J.M Flórez-CastilloJ.M Flórez-Castillo
J.M Flórez-Castillo
Currently, the detection of pathogens such as Escherichia coli through instrumental alternatives with fast response and excellent sensitivity and selectivity are being studied. Biosensors are systems consisting of nanomaterials and biomolecules that exhibit remarkable properties such as simplicity, portable, affordable, user‑friendly, and deliverable to end‑users. For this, in this work we report for the first time, to our knowledge, the bioinformatic design of a new peptide based on TIR protein, a receptor of Intimin membrane protein which is characteristic of E. coli. This peptide (named PEPTIR‑1.0) was used as recognition element in a biosensor based on AuNPs‑modified screen‑printed electrodes for the detection of E. coli. The morphological and electrochemical characteristics of the biosensor obtained were studied. Results show that the biosensor can detect the bacteria with limits of detection and quantification of 2 and 6 CFU/mL, respectively. Moreover, the selectivity of the system is statistically significant towards the detection of the pathogen in the presence of other microorganisms such as P. aeruginosa and S. aureus. This makes this new PEPTIR‑1.0 based biosensor can be used in the rapid, sensitive, and selective detection of E. coli in aqueous matrices.

12 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
LSLina M Silva
Lina M Silva
EQElizabeth Quintero
Elizabeth Quintero
ESElena Stashenko
Elena Stashenko
SCSergio Conde-Ocazionez
Sergio Conde-Ocazionez
PRPaola Rondón-Villarreal
Paola Rondón-Villarreal
RORaquel Elvira Ocazionez
Raquel Elvira Ocazionez
Currently, there are no therapies to prevent severe dengue disease. Essential oils (EOs) can serve as primary sources for research and the discovery of phytomedicines for alternative therapy. Fourteen EOs samples were obtained by distillation from six plants used in Colombian folk medicine. GC/MS analysis identified 125 terpenes. Cytopathic effect (CPE) reduction assays revealed differences in antiviral activity. EOs of Lippia alba, citral chemotype and carvone-rich fraction; Lippia origanoides, phellandrene chemotype; and Turnera diffusa, exhibited strong antiviral activity (IC50: 29 to 82 µg/mL; SI: 5.5 to 14.3). EOs of Piper aduncum, Ocimum basilicum, and L. origanoides, carvacrol, and thymol chemotypes, exhibited weak antiviral activity (32 to 53% DENV-CPE reduction at 100 µg/mL; SI > 5.0). Cluster and one-way ANOVA analyses suggest that the strong antiviral activity of EOs could be attributed to increased amounts of non-phenolic oxygenated monoterpenes and sesquiterpene hydrocarbons. Docking analyses (AutoDock Vina) predicted binding affinity between the DENV-2 E protein and terpenes: twenty sesquiterpene hydrocarbons (−8.73 to −6.91 kcal/mol), eight oxygenated monoterpenes (−7.52 to −6.98 kcal/mol), and seven monoterpene hydrocarbons (−7.60 to −6.99 kcal/mol). This study reports for the first time differences in the antiviral activity of EOs against DENV, corresponding to their composition of monoterpenes and sesquiterpenes.

12 February 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
J.M Flórez-CastilloJ.M Flórez-Castillo
J.M Flórez-Castillo
PRPaola Rondón-Villarreal
Paola Rondón-Villarreal
JRJosé Ropero
José Ropero
SMS. Y. Mendoza-Espinel
S. Y. Mendoza-Espinel
JMJ. A. Moreno-Amézquita
J. A. Moreno-Amézquita
OGOscar Gilberto Gómez-Duarte
Oscar Gilberto Gómez-Duarte
The Ib-M6 peptide has antibacterial activity against non-pathogenic Escherichia coli K-12 strain. The first part of this study determines the antibacterial activity of Ib-M6 against fourteen pathogenic strains of E. coli O157:H7. Susceptibility assay showed that Ib-M6 had values of Minimum Inhibitory Concentration (MIC) lower than streptomycin, used as a reference antibiotic. Moreover, to predict the possible interaction between Ib-M6 and outer membrane components of E. coli, we used molecular docking simulations where FhuA protein and its complex with Lipopolysaccharide (LPS–FhuA) were used as targets of the peptide. FhuA/Ib-M6 complexes had energy values between −39.5 and −40.5 Rosetta Energy Units (REU) and only one hydrogen bond. In contrast, complexes between LPS–FhuA and Ib-M6 displayed energy values between −25.6 and −40.6 REU, and the presence of five possible hydrogen bonds. Hence, the antimicrobial activity of Ib-M6 peptide shown in the experimental assays could be caused by its interaction with the outer membrane of E. coli.

1 June 2020 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
PRPaola Rondón-Villarreal
Paola Rondón-Villarreal
WLWilliam Omar Contreras López
William Omar Contreras López